InfuSystem Holdings (INFU) Operating Leases (2019 - 2026)
InfuSystem Holdings (INFU) posted Operating Leases of $3.1 million for Q1 2026, down 9.54% on a QoQ basis from $3.4 million in Q4 2025, and down 31.11% year-over-year from $4.5 million in Q1 2025.
InfuSystem Holdings (INFU) Operating Leases (2019 - 2026) Analysis & Trends
InfuSystem Holdings' Operating Leases history runs 8 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- Quarterly Operating Leases fell 31.11% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 31.11% YoY) and the FY2025 annual result came in at $3.4 million, down 24.85% from the prior year.
- Operating Leases was $3.1 million for Q1 2026 at InfuSystem Holdings, down from $3.4 million in the prior quarter.
- Across five years, Operating Leases topped out at $6.9 million in Q1 2024 and bottomed at $3.1 million in Q1 2026.
- A 5-year average of $4.6 million and a median of $4.6 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases soared 86.35% — and 2025, when it plunged 34.45%.
- InfuSystem Holdings' Operating Leases stood at $3.8 million in 2022, then surged by 54.19% to $5.8 million in 2023, then decreased by 21.37% to $4.6 million in 2024, then declined by 24.85% to $3.4 million in 2025, then fell by 9.54% to $3.1 million in 2026.
- Business Quant data shows INFU's Operating Leases at $3.1 million in Q1 2026, $3.4 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 3.43 Mn |
| Sep 30, 2025 | 5.18 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 6.87 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 4.82 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | 3.68 Mn |
| Dec 31, 2022 | 3.76 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 5.20 Mn |
| Mar 31, 2022 | 4.37 Mn |
| Dec 31, 2021 | 3.67 Mn |
| Sep 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 4.50 Mn |